How big is the Peptide Therapeutics Market?

The Peptide Therapeutics Market size is expected to reach USD 43.30 billion in 2024 and grow at a CAGR of 7.06% to reach USD 60.90 billion by 2029. Read More

What is the current Peptide Therapeutics Market size?

In 2024, the Peptide Therapeutics Market size is expected to reach USD 43.30 billion. Read More

Who are the key players in Peptide Therapeutics Market?

Eli Lilly and Company, Amgen Inc., Bristol-Myers Squibb Company, GlaxoSmithKline PLC and AstraZeneca PLC are the major companies operating in the Peptide Therapeutics Market. Read More

Which is the fastest growing region in Peptide Therapeutics Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Peptide Therapeutics Market?

In 2024, the North America accounts for the largest market share in Peptide Therapeutics Market. Read More

What years does this Peptide Therapeutics Market cover, and what was the market size in 2023?

In 2023, the Peptide Therapeutics Market size was estimated at USD 40.24 billion. The report covers the Peptide Therapeutics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Peptide Therapeutics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

What are the key challenges hindering the growth of the Peptide Therapeutics Market?

The key challenges hindering the growth of the Peptide Therapeutics Market are a) High production costs b) Complex manufacturing processes c) Limited commercialization of peptide drugs Read More

What are the key challenges hindering the growth of the Peptide Therapeutics Market?

The key challenges hindering the growth of the Peptide Therapeutics Market are a) High production costs b) Complex manufacturing processes c) Limited commercialization of peptide drugs Read More

Peptide Therapeutics Market Share

Statistics for the 2023 & 2024 Peptide Therapeutics market share, created by Mordor Intelligence™ Industry Reports. Peptide Therapeutics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

~~$4750~~

Team License

~~$5250~~

Corporate License

~~$8750~~

Buy Now

Book before:

Market Share of Peptide Therapeutics Industry

The peptide therapeutics market is highly competitive and fragmented, consisting of several major players. Some of the companies currently dominating the market are Eli Lilly and Company, Amgen Inc., Pfizer Inc., Bristol-Myers Squibb Company, Ever Neuro Pharma GmbH, Takeda Pharmaceutical Company Limited, Teva Pharmaceuticals Industries Ltd, AstraZeneca PLC, GlaxoSmithKline PLC, Novo Nordisk AS, Novartis AG, Zealand Pharma AG, and SELLAS Life Sciences Group (Galena Biopharmaceuticals).

Peptide Therapeutics Market Leaders

Eli Lilly and Company
Amgen Inc.
Bristol-Myers Squibb Company
GlaxoSmithKline PLC
AstraZeneca PLC

*Disclaimer: Major Players sorted in no particular order

Peptide Therapeutics Market Share

Market Share of Peptide Therapeutics Industry

Peptide Therapeutics Market Leaders

Peptide Therapeutics Market Report Snapshots

Peptide Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)